Cure8

Why This Matters

CMV can complicate acute colitis in people with IBD and may change treatment decisions; knowing which tests are most sensitive or specific helps clinicians decide how to work up suspected CMV colitis during hospitalizations.

Who Should Pay Attention

Clinicians caring for hospitalized IBD patients with acute colitis, researchers studying CMV diagnostics in IBD, and patients with moderate–severe IBD who are immunosuppressed or hospitalized for colitis.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

The review suggests tissue PCR is very sensitive for CMV colitis but less specific, while stool and serum PCR and pp65 antigenemia/H&E may help confirm disease when positive. Clinicians and researchers should interpret PCR results alongside clinical context and immunosuppression status.

The article is an abstract-based systematic review and meta-analysis published in Inflammatory Bowel Diseases; Cure8’s brief is grounded in the article abstract provided by the journal.

Keep In Mind

This classification and brief are grounded in the article abstract (structured content depth: abstract). The study pooled published data up to March 2025 but further research—especially to define PCR thresholds and validate stool PCR—is needed before changing practice.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationInflammatory Bowel Diseases
PublisherOxford University Press (OUP)
AuthorsSimon Mark Seddon, David Godfrey, Sheng Wei Lo +4 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 15, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →